Population Pharmacokinetics of Liposomal Amphotericin B in Immunocompromised Children

Liposomal amphotericin B (LAmB) is widely used in the treatment of invasive fungal disease (IFD) in adults and children. There are relatively limited pharmacokinetic (PK) data to inform optimal dosing in children that achieves systemic drug exposures comparable to those of adults. Our objective was...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antimicrob Agents Chemother
Main Authors: Lestner, Jodi M., Groll, Andreas H., Aljayyoussi, Ghaith, Seibel, Nita L., Shad, Aziza, Gonzalez, Corina, Wood, Lauren V., Jarosinski, Paul F., Walsh, Thomas J., Hope, William W.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2016
Assuntos:
Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5119015/
https://ncbi.nlm.nih.gov/pubmed/27697762
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01427-16
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados